免疫调节剂治疗小儿支气管哮喘的临床应用进展  

Clinical Application of Immunomodulator in Children with Bronchial Asthma

作　　者：孙亮[1] SUN Liang(Department of Pediatrics,Tianjin Third Central Hospital,Tianjin 300250,China)

机构地区：[1]天津市第三中心医院分院儿科,天津300250

出　　处：《现代诊断与治疗》2022年第3期353-356,共4页Modern Diagnosis and Treatment

摘　　要：支气管哮喘属于慢性呼吸系统疾病,慢性炎症性病变和气道高反应为该病的病理学主要表现,好发于儿童,具有治疗周期长、病情易反复发作的特点。临床治疗目的以改善患儿免疫水平、减少哮喘发作频率、缓解气道痉挛为主,近年来,免疫调节剂逐渐被应用于小儿支气管哮喘临床治疗中,并取得一定成果。对此,本文先简要分析小儿支气管哮喘的发病原因,之后就免疫调节剂治疗小儿支气管哮喘的应用情况展开讨论,分析中医药、糖皮质激素、生物制剂、化学合成剂以及微生物制剂类药物对小儿支气管哮喘的治疗效果。Bronchial asthma is a chronic respiratory disease,with the main pathological manifestations of chronic inflammatory lesion and airway hyperresponsiveness.The disease typically occurs in children and has the characteristics of long treatment cycle and high recurrence rate.The objective of clinical treatment is to improve immune level,reduce the frequency of asthma attacks and relieve airway spasm in children.In recent years,immunomodulators have been gradually applied to the clinical treatment of children with bronchial asthma and have achieved certain results.This paper briefly analyzes the causes of bronchial asthma in children,and discusses the application of immunomodulator in children with bronchial asthma.We analyze the therapeutic effect of Traditional Chinese Medicine,glucocorticoid,biological agents,chemical synthesis agent and microbial agents on children with bronchial asthma.

关 键 词：小儿支气管哮喘 免疫调节剂 免疫水平 

分 类 号：R725.6[医药卫生—儿科]